Bayer Second-Quarter Earnings Rise on Sales of New Drugs
Bayer AG 's second-quarter earnings rose 1 percent as growth in new medicines offset the effect of a strengthening euro on margins at the German company's crop and plastics units.
Xarelto Lawsuits Start To Be Filed In The US Due To "Irreversible Bleeds"
Germany-based Bayer AG is facing its first lawsuits in the United States over Xarelto, which is among the company's top-selling medications.
Bayer, ArcelorMittal and ThyssenKrupp Sue EU Over Probe
Bayer AG , ArcelorMittal SA and ThyssenKrupp AG are among 50 companies suing European Union regulators over a probe into billions of euros of German energy subsidies they may be forced to pay back.
Zacks Reiterates "Neutral" Rating for Bayer AG
's stock had its "neutral" rating reiterated by Zacks in a report issued on Friday.